spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 17 October 2007
doi: 10.1242/dev.007823


Development 134, 4011-4021 (2007)
Published by The Company of Biologists 2007


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Development
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manfroid, I.
Right arrow Articles by Peers, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manfroid, I.
Right arrow Articles by Peers, B.

Reciprocal endoderm-mesoderm interactions mediated by fgf24 and fgf10 govern pancreas development

Isabelle Manfroid1,*, François Delporte1, Ariane Baudhuin1, Patrick Motte2, Carl J. Neumann3, Marianne L. Voz1, Joseph A. Martial1 and Bernard Peers1

1 GIGA-Research-Unité de Biologie Moléculaire et Génie Génétique, Tour B34, Université de Liège, B-4000 Sart Tilman, Belgium.
2 Laboratoire de Biologie Cellulaire Végétale, Cellule d'Appui Technologique en Microscopie, Université de Liège, Institut de Botanique, Bâtiment B22, B-4000 Sart-Tilman, Belgium.
3 European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, D-69117 Heidelberg, Germany.


Figure 1
View larger version (80K):
[in this window]
[in a new window]

 
Fig. 1. isl1, fgf10 and meis3 expression adjacent to the pancreatic ventral bud. Embryos analyzed by whole-mount in situ hybridization for the expression of isl1, fgf10 and meis3. Images are ventral views of the trunk embryo, with the anterior oriented to left and the left side of the embryo to the top. (A) isl1 expression from 24 to 36 hpf. (B) fgf10 expression at 28 and 36 hpf. (C) meis3 expression from 24 to 36 hpf. Dotted yellow lines highlight the bilateral expression domain. (D) Double-labeled whole-mount in situ hybridization showing the expression of isl1, fgf10 and meis3 compared with ptf1a. Yellow arrows indicate expression of isl1, meis3 and fgf10 in a tissue adjacent to the ventral pancreatic bud. DB, dorsal pancreatic bud; FB, pectoral fin bud; VB, ventral pancreatic bud. Magnification, 200x.

 

Figure 2
View larger version (110K):
[in this window]
[in a new window]

 
Fig. 2. isl1 and meis3 label the LPM next to the developing ventral pancreatic bud. Confocal analysis of transverse sections of embryos stained by fluorescent whole-mount in situ hybridization with two probes (red and green) through the pancreatic region. Nuclear staining was achieved with TO-PRO-3 (633 nm) and artificially colored in blue. The left side of the embryo is situated to the left in all panels. (A,B) meis3 (red) and isl1 (green) expression at 30 hpf (A) and 32 hpf (B). (C) isl1 expression with mnr2a at 32 hpf. (D) Expression of fgf10 (green) and ptf1a (red) at 32 hpf. (E) isl1 (green) and ptf1a (red) expression at 35 hpf. (F) meis3 (red) and ptf1a (green) expression at 35 hpf. On transverse section in A, the white dotted lines highlight the left and right LPM. In A-F, the yellow dotted lines encircle the gut tube. The white arrows indicate the appearing ventral bud cells. Owing to the low levels of mnr2a and fgf10 expression, the views in C and D are flat stacking of several consecutive optical sections. VB, ventral pancreatic bud; DB, dorsal pancreatic bud; FB, pectoral fin bud; NT, neural tube.

 

Figure 3
View larger version (69K):
[in this window]
[in a new window]

 
Fig. 3. Inhibition of FGF signaling, but not Fgf10, impairs specification of the ventral pancreatic bud and the expression of isl1 and meis3 in the adjacent pancreatic LPM. (A) trypsin (try) expression analysis in wild-type embryos (WT, top) and in fgf10-/- mutants (dae, bottom) at 72 hpf. Note the underdeveloped pectoral fin bud in the dae mutant. (B) Expression of ptf1a (blue), isl1 and meis3 (red) at 36 hpf in embryos treated with the FGF signaling inhibitor SU5402 from 24 to 29 hpf. (C) Expression of trypsin (red) and neurod (blue) at 72 hpf after the same treatment as in B and analysis of the endodermal marker foxa1 at 36 hpf upon SU5402 treatment. Note that the liver and the rest of the endoderm are clearly labeled whereas, at this stage, the pancreas is almost undetectable. The SU5402 treatment analyzed in B and C is schematized at the bottom of the panel. (D) trypsin (blue) and isl1 (red) expression at 72 hpf in embryos exposed to SU5402 from 32 to 36 hpf and from 48 to 54 hpf. The green arrowhead indicates the ventral pancreatic bud (VB); the black arrowhead indicates the dorsal bud (DB); and the yellow arrow indicates the pancreatic LPM adjacent to the ventral bud. exo, exocrine tissue; li, liver; FB, pectoral fin bud.

 

Figure 4
View larger version (94K):
[in this window]
[in a new window]

 
Fig. 4. fgf24 is expressed in the pancreatic endoderm and in the pancreatic LPM prior to and during ventral pancreatic bud formation. (A) fgf24 (green) expression analysis by fluorescent whole-mount in situ hybridization at 24 hpf with pdx1 probe (red). A whole-mount ventral view (epifluorescence microscopy) is shown on the left panel (anterior to the left and left side of the embryo up) with anterior (a) and posterior (p) level of section. The transverse sections were analyzed by confocal microscopy, through the anterior pancreatic domain (middle panel, global view; right panel, close-up) and more posteriorly, through the dorsal pancreatic bud (right panel, close-up). (B) Expression of fgf24 (red) compared with isl1 (green) at 32 hpf (transverse section, close-up in the right panel). Expression in the pancreatic LPM is indicated by orange arrows. (C) fgf24 and isl expression at 36 hpf. fgf24 expression appears as small red grains owing to its weak expression. (D) fgf24 (green) and ptf1a (red) expression at 32 hpf. The images of transverse sections presented in B and C are flat stacking of several consecutive optical sections. DB, dorsal pancreatic bud; FB, pectoral fin bud.

 

Figure 5
View larger version (110K):
[in this window]
[in a new window]

 
Fig. 5 . fgf24 is required for the specification of the ventral pancreatic bud. (A) General morphology of a MO fgf24-injected embryo at 3 dpf compared with a control injected embryo. Identical results were obtained with mutants and morphants and illustration in morphants or mutants is stated on the images. (B) trypsin (try) and ceruloplasmin (cp) expression in fgf24 loss-of-function embryos at 3 dpf. trypsin was reduced in 80% (n=121) of embryos, whereas cp was not affected. (C) Expression of the ventral bud marker ptf1a and of the pancreatic LPM marker isl1, or of the gut marker gata6 and the pancreatic LPM gene meis3 at 36 hpf. ptf1a was absent in 32% and reduced in 59% of the embryos (n=146). isl1 was absent in 17% or reduced in 80% (n=81) of embryos, and meis3 was reduced in 72% (n=95). The orange arrows indicate expression in the pancreatic LPM. (D) fgf10 and fgf24 expression at 36 hpf in the pancreatic region in fgf24 loss-of-function embryos. fgf24 was repressed in the pancreatic LPM in 52% of the embryos (n=96). (E) ptf1a (green arrowheads) was expressed at 50 hpf in both control and the fgf24 loss-of-function embryos. DB, dorsal pancreatic bud; FB, pectoral fin buds; VB, ventral pancreatic bud.

 

Figure 6
View larger version (96K):
[in this window]
[in a new window]

 
Fig. 6. The pancreatic LPM is a target of fgf24 expressed within the endoderm. (A,B) Expression analysis of the FGF target genes pea3 (A) and erm (B) just before and during specification of the ventral pancreatic bud from 26 to 36 hpf. Right panel in A, pea3 (blue) and ptf1a (red) expression in fgf24 loss-of-function embryos. The green arrowheads indicate the ventral pancreatic bud (VB) and the orange arrows point to the pancreatic LPM. Right panel in B, erm (blue) and ptf1a (red) expression at 36 hpf. (C) Expression of ptf1a (blue) and meis3 (30 and 36 hpf) and isl1 (36 hpf) in red in casanova (cas) mutants. The yellow dotted lines underline the LPM labeled by meis3. DB, dorsal pancreatic bud; FB, pectoral fin buds.

 

Figure 7
View larger version (48K):
[in this window]
[in a new window]

 
Fig. 7. fgf24 and fgf10 cooperate to specify the ventral pancreatic bud. (A) Overall morphology of fgf10 and fgf10/fgf24 morphants at 3 dpf. Note the absence of pectoral fin buds in both morphants. (B) trypsin (try) expression at 3 dpf in embryos injected with MO control, MO fgf24, MO fgf10 and with a combination of MO fgf10 and MO fgf24. Data are presented as the percentage of embryos displaying normal, reduced, or absent expression of trypsin. (C) Expression analysis reported as in B, as the percentage of embryos expressing ptf1a in the ventral pancreatic bud and the pancreatic LPM marker isl1 in MO-injected embryos at 36 and 50 hpf. FB, pectoral fin bud; n, number of analyzed injected embryos.

 

Figure 8
View larger version (18K):
[in this window]
[in a new window]

 
Fig. 8. Three-step model for endoderm-mesoderm cross-talk controlling formation of the zebrafish ventral pancreatic bud. (A) First phase, 26-29 hpf. Early fgf24 expression within the region of the endoderm (orange) that will give rise to the pancreatic ventral bud patterns the adjacent LPM (green) into the pancreatic LPM. erm is a probable direct Fgf24 transcriptional target within the LPM. The pancreatic LPM is characterized by pea3, erm, isl1, meis3, fgf24 and fgf10 expression. fgf10 (light gray) is weakly expressed in the pancreatic LPM at these stages. (B) Second phase, 29-32 hpf. The pancreatic LPM triggers the induction at 32 hpf of ptf1a expression in endodermal cells (ptf1a-positive cells schematized in blue). fgf24 expression is restricted within the pancreatic LPM and, at the same time, fgf10 expression increases in the same tissue. pea3 and erm expression in the pancreatic LPM indicates that FGF signaling is active in this tissue. As SU5402 exposures after 26-29 hpf do not abrogate ventral bud specification, this suggests that this step is FGF-independent (signal X and white arrow). fgf10 and fgf24 are functionally redundant in patterning the pancreatic LPM, and therefore in specifying the ventral bud. At the same time, fgf24 expression disappears from the pancreatic endoderm and both fgf10 and fgf24 are expressed in the pancreatic LPM. (C) Third phase, after 32 hpf. Since SU5402 treatments after ventral bud specification limit the size of the exocrine tissue, we propose that FGF genes, perhaps fgf24 and fgf10, could be involved in mesoderm-to-endoderm communication promoting ventral pancreas growth. DB, dorsal pancreatic bud; VB, ventral pancreatic bud.

 





© The Company of Biologists Ltd 2007